Holdings (Monthly)
Guide ↗
BlackRock Health Sciences Opportunities Portfolio
· BlackRock Funds| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co. | LLY | Feb 2026 | 704,342 | $741.0M | 11.34% | EC |
| 2 | Johnson & Johnson | JNJ | Feb 2026 | 2,688,331 | $667.9M | 10.22% | EC |
| 3 | AbbVie Inc. | ABBV | Feb 2026 | 1,157,700 | $268.7M | 4.11% | EC |
| 4 | Gilead Sciences Inc. | GILD | Feb 2026 | 1,736,422 | $258.6M | 3.96% | EC |
| 5 | Merck & Co., Inc | MRK | Feb 2026 | 1,871,806 | $231.8M | 3.55% | EC |
| 6 | Amgen Inc. | AMGN | Feb 2026 | 588,158 | $228.3M | 3.49% | EC |
| 7 | UnitedHealth Group Inc. | UNH | Feb 2026 | 677,911 | $198.8M | 3.04% | EC |
| 8 | Intuitive Surgical Inc. | ISRG | Feb 2026 | 319,051 | $160.6M | 2.46% | EC |
| 9 | Abbott Laboratories | ABT | Feb 2026 | 1,361,894 | $158.5M | 2.43% | EC |
| 10 | Danaher Corporation | DHR | Feb 2026 | 716,192 | $150.9M | 2.31% | EC |
| 11 | Thermo Fisher Scientific Inc | TMO | Feb 2026 | 285,286 | $148.7M | 2.28% | EC |
| 12 | Edwards Lifesciences Corporation | EW | Feb 2026 | 1,710,975 | $147.9M | 2.26% | EC |
| 13 | Vertex Pharmaceuticals Incorporated | VRTX | Feb 2026 | 273,318 | $135.8M | 2.08% | EC |
| 14 | Medtronic PLC | MDT | Feb 2026 | 1,336,319 | $130.5M | 2.00% | EC |
| 15 | Stryker Corporation | SYK | Feb 2026 | 333,071 | $129.1M | 1.98% | EC |
| 16 | Teva Pharmaceutical Industries Ltd. | TEVA | Feb 2026 | 3,475,093 | $117.7M | 1.80% | EC |
| 17 | Cencora Inc | COR | Feb 2026 | 265,860 | $98.9M | 1.51% | EC |
| 18 | Boston Scientific Corporation | BSX | Feb 2026 | 1,284,362 | $98.7M | 1.51% | EC |
| 19 | AstraZeneca PLC | AZN | Feb 2026 | 449,772 | $94.6M | 1.45% | EC |
| 20 | Argenx SE | ARGX | Feb 2026 | 121,340 | $93.1M | 1.42% | EC |
| 21 | Mckesson Corp. | MCK | Feb 2026 | 79,662 | $78.7M | 1.20% | EC |
| 22 | Roche Holding AG | ROG | Feb 2026 | 147,789 | $70.3M | 1.08% | EP |
| 23 | Biogen Inc | BIIB | Feb 2026 | 364,188 | $69.9M | 1.07% | EC |
| 24 | Alnylam Pharmaceuticals Inc. | ALNY | Feb 2026 | 207,149 | $69.0M | 1.06% | EC |
| 25 | Regeneron Pharmaceuticals, Inc. | REGN | Feb 2026 | 87,659 | $68.5M | 1.05% | EC |
| 26 | Bristol-Myers Squibb Company | BMY | Feb 2026 | 1,097,084 | $68.4M | 1.05% | EC |
| 27 | HCA Healthcare Inc | HCA | Feb 2026 | 125,705 | $66.6M | 1.02% | EC |
| 28 | Blackrock Funds III | BISXX | Feb 2026 | 57,435,421 | $57.5M | 0.88% | STIV |
| 29 | Exact Sciences Corporation | EXAS | Feb 2026 | 548,069 | $56.7M | 0.87% | EC |
| 30 | Rhythm Pharmaceuticals Inc | RYTM | Feb 2026 | 538,793 | $50.0M | 0.76% | EC |
| 31 | IDEXX Laboratories Inc. | IDXX | Feb 2026 | 74,621 | $49.0M | 0.75% | EC |
| 32 | DexCom Inc | DXCM | Feb 2026 | 663,769 | $48.7M | 0.75% | EC |
| 33 | Penumbra Inc. | PEN | Feb 2026 | 133,216 | $45.9M | 0.70% | EC |
| 34 | Insmed Inc | INSM | Feb 2026 | 301,353 | $45.0M | 0.69% | EC |
| 35 | Novartis AG | NVS | Feb 2026 | 251,660 | $42.4M | 0.65% | EC |
| 36 | Incyte Corporation. | INCY | Feb 2026 | 396,174 | $40.1M | 0.61% | EC |
| 37 | Medline Inc. | MDLN | Feb 2026 | 842,573 | $40.0M | 0.61% | EC |
| 38 | Waters Corporation | WAT | Feb 2026 | 124,449 | $39.7M | 0.61% | EC |
| 39 | BlackRock Liquidity Funds | TSTXX | Feb 2026 | 34,195,870 | $34.2M | 0.52% | STIV |
| 40 | Protagonist Therapeutics Inc | PTGX | Feb 2026 | 370,408 | $34.1M | 0.52% | EC |
| 41 | Agilent Technologies Inc. | A | Feb 2026 | 271,239 | $32.9M | 0.50% | EC |
| 42 | Pfizer Inc. | PFE | Feb 2026 | 1,184,622 | $32.8M | 0.50% | EC |
| 43 | Nuvalent Inc | NUVL | Feb 2026 | 315,841 | $32.2M | 0.49% | EC |
| 44 | Cogent Biosciences Inc. | COGT | Feb 2026 | 820,419 | $31.9M | 0.49% | EC |
| 45 | Guardant Health Inc | GH | Feb 2026 | 336,665 | $31.6M | 0.48% | EC |
| 46 | Revolution Medicines Inc | RVMD | Feb 2026 | 302,995 | $30.9M | 0.47% | EC |
| 47 | Moderna Inc | MRNA | Feb 2026 | 560,799 | $30.0M | 0.46% | EC |
| 48 | Galderma Group AG | GALD | Feb 2026 | 153,331 | $28.9M | 0.44% | EC |
| 49 | CVS Health Corp | CVS | Feb 2026 | 359,282 | $28.7M | 0.44% | EC |
| 50 | Elevance Health Inc. | ELV | Feb 2026 | 88,605 | $28.4M | 0.43% | EC |
| 51 | United Therapeutics Corporation | UTHR | Feb 2026 | 55,689 | $28.1M | 0.43% | EC |
| 52 | NATERA INC | NTRA | Feb 2026 | 130,279 | $27.1M | 0.41% | EC |
| 53 | IQVIA Holdings Inc. | IQV | Feb 2026 | 141,190 | $25.2M | 0.39% | EC |
| 54 | The Cooper Companies, Inc. | COO | Feb 2026 | 293,135 | $24.5M | 0.38% | EC |
| 55 | Centene Corp. | CNC | Feb 2026 | 545,618 | $24.5M | 0.37% | EC |
| 56 | Biomarin Pharmaceutical Inc. | BMRN | Feb 2026 | 322,635 | $19.9M | 0.30% | EC |
| 57 | Illumina Inc | ILMN | Feb 2026 | 145,933 | $19.6M | 0.30% | EC |
| 58 | GE Healthcare Technologies Inc. | GEHC | Feb 2026 | 226,856 | $19.1M | 0.29% | EC |
| 59 | Bruker Corporation | BRKR | Feb 2026 | 471,949 | $18.9M | 0.29% | EC |
| 60 | Veeva Systems Inc | VEEV | Feb 2026 | 99,401 | $18.1M | 0.28% | EC |
| 61 | Quest Diagnostics Incorporated | DGX | Feb 2026 | 85,193 | $18.1M | 0.28% | EC |
| 62 | Repligen Corporation | RGEN | Feb 2026 | 136,584 | $17.6M | 0.27% | EC |
| 63 | Stoke Therapeutics Inc | STOK | Feb 2026 | 473,152 | $17.2M | 0.26% | EC |
| 64 | Steris PLC | STE | Feb 2026 | 64,935 | $16.4M | 0.25% | EC |
| 65 | UCB SA | UCB | Feb 2026 | 53,577 | $16.1M | 0.25% | EC |
| 66 | Terns Pharmaceuticals Inc. | TERN | Feb 2026 | 367,842 | $15.5M | 0.24% | EC |
| 67 | West Pharmaceutical Services Incorporated | WST | Feb 2026 | 60,429 | $15.4M | 0.24% | EC |
| 68 | Summit Therapeutics Inc. | SMMT | Feb 2026 | 924,148 | $15.3M | 0.23% | EC |
| 69 | Viridian Therapeutics Inc | VRDN | Feb 2026 | 516,095 | $15.2M | 0.23% | EC |
| 70 | Humana Inc. | HUM | Feb 2026 | 78,693 | $15.0M | 0.23% | EC |
| 71 | Viking Therapeutics Inc. | VKTX | Feb 2026 | 425,324 | $14.4M | 0.22% | EC |
| 72 | Apogee Therapeutics Inc. | APGE | Feb 2026 | 202,950 | $14.2M | 0.22% | EC |
| 73 | Ionis Pharmaceuticals, Inc. | IONS | Feb 2026 | 170,008 | $13.8M | 0.21% | EC |
| 74 | LB Pharmaceuticals Inc. | LBRX | Feb 2026 | 567,627 | $13.6M | 0.21% | EC |
| 75 | Bridgebio Pharma Inc | BBIO | Feb 2026 | 204,874 | $13.6M | 0.21% | EC |
| 76 | Roivant Sciences Ltd | ROIV | Feb 2026 | 468,548 | $13.6M | 0.21% | EC |
| 77 | Daiichi Sankyo Co Ltd. | 4568 | Feb 2026 | 673,800 | $13.3M | 0.20% | EC |
| 78 | Elanco Animal Health Inc | ELAN | Feb 2026 | 483,249 | $12.8M | 0.20% | EC |
| 79 | Cytokinetics Inc | CYTK | Feb 2026 | 184,777 | $11.5M | 0.18% | EC |
| 80 | Bio-Techne Corp | TECH | Feb 2026 | 193,925 | $11.4M | 0.18% | EC |
| 81 | MBX Biosciences, Inc. | MBX | Feb 2026 | 333,350 | $10.9M | 0.17% | EC |
| 82 | Arcellx Inc | ACLX | Feb 2026 | 92,964 | $10.6M | 0.16% | EC |
| 83 | Glaukos Corp. | GKOS | Feb 2026 | 87,150 | $10.5M | 0.16% | EC |
| 84 | Hologic Inc | HOLX | Feb 2026 | 138,368 | $10.4M | 0.16% | EC |
| 85 | Agios Pharmaceuticals Inc | AGIO | Feb 2026 | 344,876 | $10.4M | 0.16% | EC |
| 86 | Neurocrine Biosciences Inc | NBIX | Feb 2026 | 78,721 | $10.4M | 0.16% | EC |
| 87 | Exelixis, Inc. | EXEL | Feb 2026 | 231,652 | $10.2M | 0.16% | EC |
| 88 | ADARX PHARMACEUTICALS INC | 000000000 | Feb 2026 | 769,230 | $10.1M | 0.15% | EC |
| 89 | Charles River Laboratories International, Inc. | CRL | Feb 2026 | 56,177 | $10.0M | 0.15% | EC |
| 90 | Scholar Rock Holding Corp. | SRRK | Feb 2026 | 226,209 | $10.0M | 0.15% | EC |
| 91 | Eikon Therapeutics Inc. | EIKN | Feb 2026 | 722,389 | $10.0M | 0.15% | EC |
| 92 | Erasca Inc | ERAS | Feb 2026 | 709,864 | $9.7M | 0.15% | EC |
| 93 | Arcus Biosciences Inc. | RCUS | Feb 2026 | 455,542 | $9.3M | 0.14% | EC |
| 94 | Alumis Inc | ALMS | Feb 2026 | 293,662 | $8.7M | 0.13% | EC |
| 95 | Maze Therapeutics Inc | MAZE | Feb 2026 | 184,453 | $8.4M | 0.13% | EC |
| 96 | LARONDE INC | 000000000 | Feb 2026 | 386,520 | $8.4M | 0.13% | EC |
| 97 | Ventyx Biosciences Inc. | VTYX | Feb 2026 | 590,649 | $8.3M | 0.13% | EC |
| 98 | Bright Minds Biosciences Inc | DRUG | Feb 2026 | 95,655 | $8.0M | 0.12% | EC |
| 99 | Novocure Ltd | NVCR | Feb 2026 | 574,295 | $7.9M | 0.12% | EC |
| 100 | Edgewise Therapeutics Inc. | EWTX | Feb 2026 | 256,164 | $7.8M | 0.12% | EC |
| 101 | Radnet Inc | RDNT | Feb 2026 | 108,100 | $7.5M | 0.12% | EC |
| 102 | Avidity Biosciences Inc. | RNAM | Feb 2026 | 99,483 | $7.2M | 0.11% | EC |
| 103 | Intellia Therapeutics Inc | NTLA | Feb 2026 | 518,392 | $7.1M | 0.11% | EC |
| 104 | Enanta Pharmaceuticals Inc | ENTA | Feb 2026 | 492,001 | $7.0M | 0.11% | EC |
| 105 | KARTOS THERAPEUTICS INC | 000000000 | Feb 2026 | 1,233,856 | $7.0M | 0.11% | EC |
| 106 | Denali Therapeutics Inc | DNLI | Feb 2026 | 329,179 | $7.0M | 0.11% | EC |
| 107 | BridgeBio Oncology Therapeutics Inc. | BBOT | Feb 2026 | 673,766 | $6.8M | 0.10% | EC |
| 108 | Angitia Biopharmaceuticals Limited | 000000000 | Feb 2026 | 658,956 | $6.5M | 0.10% | EC |
| 109 | Oruka Therapeutics Inc | ORKA | Feb 2026 | 185,015 | $6.4M | 0.10% | EC |
| 110 | Immunome Inc | IMNM | Feb 2026 | 288,792 | $6.3M | 0.10% | EC |
| 111 | Mettler-Toledo International Inc | MTD | Feb 2026 | 4,594 | $6.3M | 0.10% | EC |
| 112 | Olema Pharmaceuticals Inc. | OLMA | Feb 2026 | 253,931 | $6.1M | 0.09% | EC |
| 113 | Immunocore Holdings plc | IMCR | Feb 2026 | 188,691 | $6.1M | 0.09% | EC |
| 114 | KAILERA THERAPEUTICS INC | 000000000 | Feb 2026 | 428,000 | $6.0M | 0.09% | EC |
| 115 | Dianthus Therapeutics Inc | DNTH | Feb 2026 | 108,033 | $6.0M | 0.09% | EC |
| 116 | Disc Medicine Inc | IRON | Feb 2026 | 86,558 | $5.8M | 0.09% | EC |
| 117 | Alcon AG | ALC | Feb 2026 | 65,553 | $5.7M | 0.09% | EC |
| 118 | PTC Therapeutics, Inc. | PTCT | Feb 2026 | 82,970 | $5.7M | 0.09% | EC |
| 119 | Monte Rosa Therapeutics Inc | GLUE | Feb 2026 | 318,162 | $5.6M | 0.09% | EC |
| 120 | Vaxcyte Inc | PCVX | Feb 2026 | 87,540 | $5.4M | 0.08% | EC |
| 121 | Aktis Oncology Inc. | AKTS | Feb 2026 | 266,503 | $5.4M | 0.08% | EC |
| 122 | Kodiak Sciences Inc | KOD | Feb 2026 | 188,769 | $5.1M | 0.08% | EC |
| 123 | INSITRO INC | 000000000 | Feb 2026 | 592,636 | $5.0M | 0.08% | EC |
| 124 | Kymera Therapeutics Inc | KYMR | Feb 2026 | 54,173 | $4.9M | 0.08% | EC |
| 125 | GENESIS THERAPEUTICS INC | 000000000 | Feb 2026 | 823,870 | $4.9M | 0.07% | EC |
| 126 | Wave Life Sciences Ltd. | WVE | Feb 2026 | 345,882 | $4.8M | 0.07% | EC |
| 127 | Beam Therapeutics Inc. | BEAM | Feb 2026 | 168,010 | $4.8M | 0.07% | EC |
| 128 | QUANTA DIALYSIS TECHNOLOGIES LTD | 000000000 | Feb 2026 | 80,024,425 | $4.6M | 0.07% | EC |
| 129 | BioNTech SE | BNTX | Feb 2026 | 41,921 | $4.6M | 0.07% | EC |
| 130 | Dyne Therapeutics Inc. | DYN | Feb 2026 | 278,934 | $4.4M | 0.07% | EC |
| 131 | Zealand Pharma As | ZEAL | Feb 2026 | 74,091 | $4.3M | 0.07% | EC |
| 132 | Biohaven Ltd | BHVN | Feb 2026 | 348,832 | $4.0M | 0.06% | EC |
| 133 | CG Oncology Inc. | CGON | Feb 2026 | 59,514 | $3.5M | 0.05% | EC |
| 134 | KalVista Pharmaceuticals Inc. | KALV | Feb 2026 | 212,587 | $3.5M | 0.05% | EC |
| 135 | Allogene Therapeutics Inc | ALLO | Feb 2026 | 1,208,862 | $3.4M | 0.05% | EC |
| 136 | Eyepoint Inc. | EYPT | Feb 2026 | 186,478 | $3.3M | 0.05% | EC |
| 137 | Upstream Bio Inc | UPB | Feb 2026 | 341,675 | $2.6M | 0.04% | EC |
| 138 | Ocular Therapeutix Inc | OCUL | Feb 2026 | 258,781 | $2.3M | 0.04% | EC |
| 139 | BRIDGEBIO ONCOLOGY THERAPEUTICS INC | 000000000 | Feb 2026 | 209,287 | $2.1M | 0.03% | EC |
| 140 | CELLARITY INC | 000000000 | Feb 2026 | 858,333 | $2.1M | 0.03% | EC |
| 141 | Corvus Pharmaceuticals Inc | CRVS | Feb 2026 | 110,424 | $2.0M | 0.03% | EC |
| 142 | Regenxbio Inc. | RGNX | Feb 2026 | 214,663 | $1.9M | 0.03% | EC |
| 143 | KARTOS THERAPEUTICS INC | 000000000 | Feb 2026 | 339,469 | $1.9M | 0.03% | EC |
| 144 | Vor Biopharma Inc. | VOR | Feb 2026 | 115,078 | $1.8M | 0.03% | EC |
| 145 | Voyager Therapeutics Incorporation | VYGR | Feb 2026 | 371,161 | $1.5M | 0.02% | EC |
| 146 | Nyxoah Sa | NYXH | Feb 2026 | 337,359 | $1.4M | 0.02% | EC |
| 147 | Autolus Therapeutics PLC | AUTL | Feb 2026 | 728,967 | $1.2M | 0.02% | EC |
| 148 | 4D Molecular Therapeutics Inc | FDMT | Feb 2026 | 126,274 | $1.2M | 0.02% | EC |
| 149 | GOLDFINCH BIO INC | 000000000 | Feb 2026 | 3,115,353 | $935K | 0.01% | EC |
| 150 | Orchestra BioMed Holdings Inc | OBIO | Feb 2026 | 206,130 | $903K | 0.01% | EC |
| 151 | EXO IMAGING INC | 000000000 | Feb 2026 | 890,877 | $659K | 0.01% | EP |
| 152 | TScan Therapeutics Inc | TCRX | Feb 2026 | 556,653 | $590K | 0.01% | EC |
| 153 | Abiomed Inc | 2223637D | Feb 2026 | 243,643 | $565K | 0.01% | — |
| 154 | KARTOS THERAPEUTICS INC | 000000000 | Feb 2026 | 491,515 | $494K | 0.01% | EC |
| 155 | AFFINIVAX INC | 000000000 | Feb 2026 | 122,824 | $451K | 0.01% | EC |
| 156 | BLUEPRINT MEDICINES CORP | BPMC | Feb 2026 | 204,909 | $205K | 0.00% | EC |
| 157 | MIRATI THERAPEUTICS INC | MRTX | Feb 2026 | 228,510 | $181K | 0.00% | EC |
| 158 | Gossamer Bio Inc | GOSS | Feb 2026 | 365,199 | $155K | 0.00% | EC |
| 159 | Atrium Therapeutics Inc. | RNA | Feb 2026 | 9,948 | $147K | 0.00% | EC |
| 160 | EXO IMAGING INC | 000000000 | Feb 2026 | 19,083 | $7K | 0.00% | EC |
| 161 | SWIFT HEALTH SYSTEMS INC | 000000000 | Feb 2026 | 1,700 | $4K | 0.00% | EC |
| 162 | AFFERENT PHARMACEUTICAL | 000000000 | Feb 2026 | 3,420,640 | $34 | 0.00% | EP |
| 163 | CARBON HEALTH TECHNOLOGIES INC | 000000000 | Feb 2026 | 2,720,277 | $27 | 0.00% | EC |
| 164 | FREQUENCY THERAPEUTICS CVR | 000000000 | Feb 2026 | 428,010 | $4 | 0.00% | EC |
| 165 | GOLDFINCH EQUITY | 000000000 | Feb 2026 | 403,447 | $4 | 0.00% | DE |